| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Samuel Rubinstein | Director | 2025-11-18 | 2,168 | $1.40 | $3.04kBuy |
| Samuel Rubinstein | Director | 2025-11-18 | 2,832 | $1.41 | $3.99kBuy |
| Samuel Rubinstein | Director | 2025-11-17 | 5,500 | $1.32 | $7.26kSell |
| Samuel Rubinstein | Director | 2025-11-17 | 7,200 | $1.34 | $9.65kSell |
| Samuel Rubinstein | Director | 2025-11-17 | 1,394 | $1.36 | $1.90kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Accelmed Growth Partners LP | 1,027.27% | 60,487,545 | $72.59M | Insider |
| URI Geiger | 228.91% | 13,478,872 | $16.17M | Insider |
| Accelmed Partners LP | 97.95% | 5,767,340 | $6.92M | Insider |
| Bonanza Capital Ltd | 79.76% | 4,696,474 | $5.64M | Insider |
| 22nw LP | 59.73% | 3,516,898 | $4.22M | Insider |
| Bonanza Master Fund Ltd | 53.69% | 3,161,400 | $3.79M | Insider |
| Broadfin Capital LLC | 43.28% | 2,548,594 | $3.06M | Insider |
| Broadfin Healthcare Master Fund Ltd | 17.12% | 1,008,297 | $1.21M | Insider |
| Austin W. Greenhouse David M. Marxe | 12.94% | 761,726 | $914.07k | Insider |
| Dan W. Lufkin | 12.80% | 753,398 | $904.08k | Insider |